Sympathoadrenal activity and sleep: in the search for a marker of hyperarousal in insomnia

Objective. To assess subjective and objective sleep characteristics and urinary metanephrine levels in patients with insomnia. 
Design and methods. We included patients with insomnia complaints and those without sleep– related complaints (control group) 18–75 years old. Subjective evaluation of the main sleep characteristics during the last month was assessed by the Pittsburgh Sleep Quality questionnaire, daytime sleepiness — by the Epworth Sleepiness Scale. For objective sleep evaluation we performed one-night polysomnography (PSG). Within 1 week after the PSG, daily urine was collected to determine the level of metaepinephrine. 
Results. The groups did not differ by age, mean sleep duration over the past month, number of night awakenings by the Pittsburgh Questionnaire, and level of daytime sleepiness. Sleep latency in insomnia group was 15 minutes longer than in the control group. PSG showed higher apnea-hypopnea and desaturation indices in the control group. There were no differences in daily urinary metanephrine excretion in the main and control groups. Correlation analysis showed no significant association between the metanephrine levels and the severity of somnolence and the index of periodic limb movements. 
Conclusions. Our analysis showed no significant differences in the daily urine metanephrine levels and the main PSG sleep characteristics among subjects with and without insomnia. Further work is required to clarify markers of insomnia and their negative health effects.

1. Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest. 2017;152(2):435–444. doi.org/10.1016/j.chest.2017.01.026

2. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. doi:10.1378/chest.14-0970

3. Hjemdahl P. Plasma catecholamines—analytical challenges and physiological limitations. Bailliere’s clinical endocrinology and metabolism. 1993;7(2):307–353.

4. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psych Res. 1989;28(2):193–213. doi:10.1016/0165-1781(89)90047-4

5. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545.

6. Berry RB, Brooks R, Gamaldo CE, Harding SM, Marcus CL, Vaughn BV. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.5. Darien, IL: American Academy of Sleep Medicine, 2018.

7. Newell J, Mairesse O, Verbanck P, Neu D. Is a one-night stay in the lab really enough to conclude? First-night effect and night-to-night variability in polysomnographic recordings among different clinical population samples. Psychiatry research. 2012;200(2–3):795–801.

8. Gortseva AY, Korostovtseva LS, Bochkarev MV, Sviryaev YV, Konradi AO. Determination of the role of subjective methods of examination in evaluation of qualitative characteristics of sleep. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(4–2):34–41. doi:10.17116/jnevro20171174234-41. In Russian.

9. Vanable PA, Aikens JE, Tadimeti L, Caruana-Montaldo B, Mendelson WB. Sleep latency and duration estimates among sleep disorder patients: Variability as a function of sleep disorder diagnosis, sleep history, and psychological characteristics. Sleep. 2000;23(1):71–79. doi:10.1093/sleep/23.1.1d

10. Agaltsov MV. Respiratory disorders in sleep: the current state of the problem. Arterial’naya Gipertenziya = Arterial Hypertension. 2014;20(3):201–211. doi:10.18705/1607-419X‑2014-20-3-201-211. In Russian.

11. Grimaldi D, Reid KJ, Papalambros NA, Braun RI, Malkani RG, Abbott SM et al. Autonomic dysregulation and sleep homeostasis in insomnia. Sleep. 2021;44(6): zsaa274. doi:10.1093/sleep/zsaa274

12. Vgontzas AN, Bixler EO, Lin H, Prolo P, Mastorakos G, Vela-Bueno A et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86(8):3787–3794. doi:10.1210/jcem.86.8.7778